DFTX FY 2025 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DFTXDefinium Therapeutics, Inc.

$2B

FY 2025 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$166M

Net Income

-$184M

EPS (Diluted)

$-2.06

Cash Flow

Operating Cash Flow

-$132M

Free Cash Flow

-$132M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$440M

Total Liabilities

$108M

Stockholders' Equity

$332M

Cash & Equivalents

$258M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$527,000	+100.0%
Operating Income	-$166M	-$104M	-60.0%
Net Income	-$184M	-$109M	-69.1%